Severe Hypomagnesemia During Long-term Treatment With a Proton Pump Inhibitor

被引：58
|
作者：
Regolisti, Giuseppe [1 ]
Cabassi, Aderville [1 ]
Parenti, Elisabetta [1 ]
Maggiore, Umberto [1 ]
Fiaccadori, Enrico [1 ]
机构：
[1] Univ Parma, Dipartimento Clin Med Nefrol & Sci Prevenz, I-43100 Parma, Italy
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2010年 / 56卷 / 01期
关键词：
Hypomagnesemia; proton pump inhibitors; BARTTERS-SYNDROME; SENSORINEURAL DEAFNESS; INTENSIVE-CARE; INTESTINAL-ABSORPTION; HYPOKALEMIC ALKALOSIS; MAGNESIUM LOSS; MUTATIONS; GENE; HYPOCALCEMIA; OMEPRAZOLE;
D O I：
10.1053/j.ajkd.2010.03.013
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：168 / 174
页数：7
相关论文
共 50 条
  • [31] Proton pump inhibitor therapy and potential long-term harm
    Corleto, Vito Domenico
    Festa, Stefano
    Di Giulio, Emilio
    Annibale, Bruno
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2014, 21 (01) : 3 - 8
  • [32] Helicobacter pylori eradication is not necessary before long-term proton pump inhibitor treatment
    Freston, JW
    HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2002, 2003, : 311 - 317
  • [33] Why and how withdrawing treatment with proton pump inhibitor after long-term use?
    de Korwin, J. -D.
    REVUE DE MEDECINE INTERNE, 2012, 33 (08): : 417 - 420
  • [34] LONG-TERM OUTCOMES AND DURABILITY OF RESPONSE TO PROTON PUMP INHIBITOR TREATMENT IN EOSINOPHILIC ESOPHAGITIS
    Thakkar, Kisan
    Fowler, Mark
    Keene, Staci
    Dellon, Evan S.
    GASTROENTEROLOGY, 2021, 160 (06) : S256 - S257
  • [35] What is worth to remember during long-term treatment with proton pump inhibitors?
    Wocial, Tomasz
    PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2013, 9 (02): : 126 - 132
  • [36] Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort
    Sharara, Ala I.
    Chalhoub, Jean M.
    Hammoud, Nijmeh
    Harb, Ali H.
    Sarkis, Fayez S.
    Hamadeh, Ghassan
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (02) : 317 - 321
  • [37] SEVERE HYPOMAGNESAEMIA WITH SECONDARY HYPOCALCAEMIA DUE TO LONG-TERM PROTON PUMP INHIBITOR USE: A CASE SERIES
    Choy, Kay Hau
    INTERNAL MEDICINE JOURNAL, 2019, 49 : 23 - 24
  • [38] EVALUATION OF ENTEROCHROMAFFIN-LIKE (ECL)-CELL HYPERPLASIA DURING LONG-TERM TREATMENT WITH THE PROTON PUMP INHIBITOR LANSOPRAZOLE
    EISSELE, R
    BRUNNER, G
    FISCHER, B
    FUCHS, W
    KOOP, H
    ARNOLD, R
    GASTROENTEROLOGY, 1993, 104 (04) : A74 - A74
  • [39] Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy
    Jalving, M.
    Koornstra, J. J.
    Wesseling, J.
    Boezen, H. M.
    De Jong, S.
    Kleibeuker, J. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (09) : 1341 - 1348
  • [40] Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis
    Horvath, Angela
    Rainer, Florian
    Bashir, Mina
    Leber, Bettina
    Schmerboeck, Bianca
    Klymiuk, Ingeborg
    Groselj-Strele, Andrea
    Durdevic, Marija
    Freedberg, Daniel E.
    Abrams, Julian A.
    Fickert, Peter
    Stiegler, Philipp
    Stadlbauer, Vanessa
    SCIENTIFIC REPORTS, 2019, 9 (1)
12345